Tag: Rintatolimod

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Rintatolimod

AIM ImmunoTech Announces Two Year Extension of Agreement with Shenzhen Smoore ...

Added to Collection on: 2021-05-27 12:45:00

Tags for this article:

Health
Medical specialties
Occupational safety and health
Atypical pneumonias
Rintatolimod
AIM ImmunoTech
Clinical research
Drug discovery
Pharmaceutical industry
COVID-19
Clinical trial
Severe acute respiratory syndrome
AIM ImmunoTech Inc.
ImmunoTech Inc
Smoore International Holdings Limited
Shenzhen Smoore Technology Limited

Click the tags to see associated articles and topics

View Article Details
Other news to note for May 27, 2021

Added to Collection on: 2021-05-27 23:08:13

Tags for this article:

Life Sciences
Health care
Health sciences
Medical research
AstraZeneca
Södertälje Municipality
Pfizer
COVID-19 vaccine
Rintatolimod
Vaccine
Hepatitis B vaccine
Hepatitis

Click the tags to see associated articles and topics

View Article Details
NA Proactive news snapshot: Delta 9 Cannabis, North Arrow Minerals, Empower Clinics, NEO ...

Added to Collection on: 2021-06-21 13:52:30

Tags for this article:

Medical specialties
Drugs
Medicine
AIM ImmunoTech
Rintatolimod
Leronlimab
HU-308
Acute respiratory distress syndrome
OTC Markets Group
Pfizer-BioNTech COVID-19 vaccine
Anode
CYTODYN INC

Click the tags to see associated articles and topics

View Article Details
Further trial disruptions due to the Russian invasion of Ukraine

Added to Collection on: 2022-05-19 14:25:17

Tags for this article:

Health sciences
Health
Pharmaceutical industry
Clinical research
Drug discovery
Design of experiments
Orphan drugs
Clinical trial
Rintatolimod
Russia
Ukraine

Click the tags to see associated articles and topics

View Article Details
Hemispherx BioPharma (NYSEAMERICAN:HEB) Shares Cross Above Two Hundred Day ...

Added to Collection on: 2023-11-03 08:02:58

Tags for this article:

AIM ImmunoTech
Drugs
Rintatolimod
Chronic fatigue syndrome
Health care
Medical specialties
HEB
Chronic fatigue syndrome treatment
Hemispherx Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Added to Collection on: 2022-08-15 12:25:42

Tags for this article:

Clinical medicine
Medicine
Cancer
Oncology
RTT
Rintatolimod
Breast cancer
Cancer treatments
Triple-negative breast cancer
Pembrolizumab
Ovarian cancer
Adjuvant therapy
Netherlands
AIM ImmunoTech Inc.
Ampligen

Click the tags to see associated articles and topics

View Article Details
Hemispherx BioPharma (NYSEAMERICAN:HEB) Share Price Crosses Above 200 Day ...

Added to Collection on: 2024-02-23 08:55:32

Tags for this article:

Hemispherx Biopharma
Rintatolimod
Chronic fatigue syndrome
HEB
Chronic fatigue syndrome treatment
Medicine
Health care
Clinical medicine
Hemispherx Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Hemispherx BioPharma (NYSEAMERICAN:HEB) Stock Price Crosses Above Two Hundred ...

Added to Collection on: 2022-10-28 07:03:51

Tags for this article:

Hemispherx Biopharma
Rintatolimod
Chronic fatigue syndrome
HEB
Life Sciences
Chronic fatigue syndrome treatment
Companies
Bristol-Myers Squibb
Dividend
Medical specialties
Hemispherx Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech doses first subject in Phase 2 study of Ampligen, Imfinzi | Markets Insider

Added to Collection on: 2025-02-25 14:54:28

Tags for this article:

Orphan drugs
Cancer immunotherapy
Rintatolimod
Durvalumab
Live attenuated influenza vaccine
AIM ImmunoTech
Checkpoint inhibitor
Ampligen
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech Advances Pancreatic Cancer Trial to Phase 2 with Ampligen-Imfinzi Combination

Added to Collection on: 2025-02-25 13:41:23

Tags for this article:

Orphan drugs
Durvalumab
Cancer immunotherapy
Checkpoint inhibitor
Rintatolimod
AstraZeneca
AIM ImmunoTech
PD-L1
Thomas K. Equels

Click the tags to see associated articles and topics

View Article Details